Intuitive Surgical, Inc.

(NASDAQ Global Select)
Back to all articles
Somewhat Bullish +42

Intuitive Surgical (ISRG): Does Leasing Make Growth More Durable or More Capital Intensive?

Company update AI-generated analysis

πŸ“ˆ Operating lease revenue increased 22% to $262 million in the second quarter, outpacing systems revenue growth of 19%.

πŸ” Worldwide da Vinci procedures rose 15% while utilization increased 3%, demonstrating that busier systems generate additional sales beyond lease payments.

πŸ’° Intuitive Surgical generated $1.97 billion of first-half operating cash flow, leaving approximately $1.76 billion after property and equipment purchases.

πŸ“‰ The company trades at a demanding 33x forward P/E valuation compared to 16x for peer Stryker Corporation.

⚠️ U.S. procedure growth eased to 12% versus 20% outside the United States, linked by management to expired enhanced health-insurance subsidies.

πŸ“Š Analysts expect calendar-2026 non-GAAP adjusted EPS growth of approximately 21% for Intuitive Surgical versus 10% for Stryker.

Bullish Signals
  • Operating lease revenue increased 22% to $262 million in the second quarter, ahead of 19% systems revenue growth.
  • Worldwide da Vinci procedures rose 15% while utilization increased 3%, demonstrating that busier systems generate additional sales beyond lease payments.
  • Instruments and accessories revenue rose 18%, showing how usage-based arrangements drive incremental profits.
  • The company generated $1.97 billion of first-half operating cash flow, leaving approximately $1.76 billion after property and equipment purchases.
  • Analysts expect calendar-2026 non-GAAP adjusted EPS growth of approximately 21%, significantly outpacing peer Stryker's expected 10% growth.
Risk Factors
  • The company trades at a demanding 33x forward P/E valuation compared to 16x for peer Stryker Corporation, requiring sustained performance to justify the premium.
  • U.S. procedure growth eased to 12% versus 20% outside the United States, linked by management to expired enhanced health-insurance subsidies.
  • Leasing makes the business more capital intensive as shareholders fund equipment before collecting lifetime returns, tying up investment longer than outright sales.
  • Slower expansion and continuing investment requirements support a lower valuation than previous levels, with forward P/E compressing from 59x to 38x.
Full Analysis
Intuitive Surgical (ISRG) is expanding hospital adoption of its da Vinci robotic systems through leasing, with operating leases accounting for 54% of second-quarter placements compared to 49% a year prior. This strategy lowers upfront costs for hospitals but requires shareholders to fund equipment before collecting lifetime returns, making the business more capital intensive while sustaining growth. The company trades at a premium valuation of 33x forward P/E versus Stryker's 16x, justified by analysts expecting 21% non-GAAP adjusted EPS growth in 2026 compared to Stryker's 10%. However, the high multiple demands sustained procedure volumes and cash returns to cover equipment costs, as slower expansion and continued investment requirements support a lower valuation than previous levels. Financial performance remains robust with second-quarter GAAP EPS of $2.29 and adjusted EPS of $2.80, supported by $1.97 billion in first-half operating cash flow. While usage-based arrangements match hospital payments to procedures, industry conditions like expired health-insurance subsidies have slowed U.S. procedure growth, creating risks for instrument demand and equipment utilization.